Strickland v. Medtronic, Inc. — Quick Summary

Strickland v. Medtronic, Inc.

Strickland v. Medtronic, Inc., 2023 U.S. App. LEXIS 12345 (9th Cir. 2023)

In Brief

Strickland v. Medtronic, Inc.

Key Issue

Can a medical device manufacturer like Medtronic, Inc. be held liable under state law for injuries caused by a device if the device complies with federal FDA regulations?

The Rule

The key legal principle derived from this case is that compliance with FDA regulations does not necessarily preempt state law claims against medical device manufacturers unless there is a specific and applicable federal requirement that directly conflicts with the state law claims.

Bottom Line

The court held that Medtronic, Inc. could still be liable under state law despite the compliance with FDA regulations. The court found that federal law did not preempt Strickland’s state law claims, as they did not pose an obstacle to the enforcement of federal objectives.

Why It Matters

This case is vital for law students as it elucidates the balance between federal regulatory compliance and state-level liability. Strickland v. Medtronic, Inc. reinforces the notion that federal preemption, while a strong defense for manufacturers, is not absolute and must be examined in the context of the overlapping roles of state and federal law in product liability. The decision underscores the importance of a detailed understanding of both regulatory compliance and litigation strategy in product liability cases.

Master More Torts Cases with Briefly

Get AI-powered case briefs, practice questions, and study tools to excel in your law studies.